CRCA ETF Chart
NYSEARCA: CRCAProSharesTrading--Leveraged EquityETFUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 19.14 +5.19%
CRCA technical summary
CRCA is trading 5.9% below its 50-day simple moving average of $19.35 and 43.5% below its 200-day average of $32.26. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 46.2, within the neutral 30 to 70 band.
Over the past year, the stock ranged from $10.07 (Aug 3, 2026) to $167.10 (Oct 27, 2025); the current price sits 5% of the way from the low to the high. Annualized 30-day volatility is 181.0%. Based on the last session's high, low and close, the classic pivot point is $18.06, with first resistance at $19.63 and first support at $16.66.
These indicators describe past price behavior for ProShares Ultra CRCL; they are not predictions.
Summary generated from market data by MetaCap's automated system. Methodology
CRCA performance
1 week
+7.18%
1 month
-22.73%
3 months
+30.24%
6 months
-46.90%
Year to date
-54.90%
1 year
-87.83%
CRCA price return, excluding dividends.
Moving averages
| Period | Simple (SMA) | Exponential (EMA) |
|---|---|---|
| 5-day | 17.58Price above | 17.80Price above |
| 10-day | 18.05Price above | 18.39Price below |
| 20-day | 19.88Price below | 19.39Price below |
| 50-day | 19.35Price below | 20.22Price below |
| 100-day | 21.41Price below | 24.40Price below |
| 200-day | 32.26Price below | 36.20Price below |
Pivot points
| Level | Price |
|---|---|
| Resistance 3 (R3) | 22.60 |
| Resistance 2 (R2) | 21.03 |
| Resistance 1 (R1) | 19.63 |
| Pivot point | 18.06 |
| Support 1 (S1) | 16.66 |
| Support 2 (S2) | 15.09 |
| Support 3 (S3) | 13.69 |